Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 17

1.

Monitoring redox-sensitive paramagnetic contrast agent by EPRI, OMRI and MRI.

Hyodo F, Murugesan R, Matsumoto K, Hyodo E, Subramanian S, Mitchell JB, Krishna MC.

J Magn Reson. 2008 Jan;190(1):105-12. Epub 2007 Oct 30.

2.

Therapeutic and clinical applications of nitroxide compounds.

Soule BP, Hyodo F, Matsumoto K, Simone NL, Cook JA, Krishna MC, Mitchell JB.

Antioxid Redox Signal. 2007 Oct;9(10):1731-43. Review.

PMID:
17665971
3.

Comparisons of EPR imaging and T1-weighted MRI for efficient imaging of nitroxyl contrast agents.

Matsumoto K, Narazaki M, Ikehira H, Anzai K, Ikota N.

J Magn Reson. 2007 Jul;187(1):155-62. Epub 2007 Mar 24.

PMID:
17433743
4.

Probing the intracellular redox status of tumors with magnetic resonance imaging and redox-sensitive contrast agents.

Hyodo F, Matsumoto K, Matsumoto A, Mitchell JB, Krishna MC.

Cancer Res. 2006 Oct 15;66(20):9921-8.

5.

Spatially resolved time-course studies of free radical reactions with an EPRI/MRI fusion technique.

Hyodo F, Yasukawa K, Yamada K, Utsumi H.

Magn Reson Med. 2006 Oct;56(4):938-43.

7.

Electron paramagnetic resonance imaging of oxidative stress in renal disease.

Hirayama A, Nagase S.

Nephron Clin Pract. 2006;103(2):c71-6. Epub 2006 Mar 10. Review.

PMID:
16543759
8.

In vivo proton electron double resonance imaging of the distribution and clearance of nitroxide radicals in mice.

Li H, He G, Deng Y, Kuppusamy P, Zweier JL.

Magn Reson Med. 2006 Mar;55(3):669-75.

9.

In vivo detection of gastric cancer in rats by electron paramagnetic resonance imaging.

Mikuni T, He G, Petryakov S, Fallouh MM, Deng Y, Ishihara R, Kuppusamy P, Tatsuta M, Zweier JL.

Cancer Res. 2004 Sep 15;64(18):6495-502.

10.

Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications.

Gallez B, Baudelet C, Jordan BF.

NMR Biomed. 2004 Aug;17(5):240-62. Review.

PMID:
15366026
11.

Cardiac applications of EPR imaging.

Kuppusamy P, Zweier JL.

NMR Biomed. 2004 Aug;17(5):226-39. Review.

PMID:
15366025
12.

In vivo EPR: when, how and why?

Gallez B, Swartz HM.

NMR Biomed. 2004 Aug;17(5):223-5.

PMID:
15366024
13.

Mapping ischemic risk region and necrosis in the isolated heart using EPR imaging.

Velayutham M, Li H, Kuppusamy P, Zweier JL.

Magn Reson Med. 2003 Jun;49(6):1181-7.

14.

Hemodynamic effect of the nitroxide superoxide dismutase mimics.

Hahn SM, Sullivan FJ, DeLuca AM, Bacher JD, Liebmann J, Krishna MC, Coffin D, Mitchell JB.

Free Radic Biol Med. 1999 Sep;27(5-6):529-35.

PMID:
10490272
15.

In vivo L-band ESR and quantitative pharmacokinetic analysis of stable spin probes in rats and mice.

Nishino N, Yasui H, Sakurai H.

Free Radic Res. 1999 Jul;31(1):35-51.

PMID:
10489118
16.
17.

Effects of nitroxides on the magnetic field and temperature dependence of 1/T1 of solvent water protons.

Bennett HF, Brown RD 3rd, Koenig SH, Swartz HM.

Magn Reson Med. 1987 Feb;4(2):93-111.

PMID:
3031423

Supplemental Content

Support Center